Quarterly report pursuant to Section 13 or 15(d)

Condensed Statement of Changes in Shareholders' Equity

v3.21.1
Condensed Statement of Changes in Shareholders' Equity - 3 months ended Mar. 31, 2021 - USD ($)
Total
Additional Paid-in Capital
Accumulated Deficit
Class A Ordinary Shares
Class B Ordinary Shares
Beginning balance at Dec. 31, 2020 $ 6,380 $ 22,556 $ (18,620) $ 0 $ 2,444
Beginning balance (in shares) at Dec. 31, 2020       0 24,437,500
Sale of units in initial public offering, gross 957,730,890 957,721,115   $ 9,775  
Sale of units in initial public offering, gross (in shares)       97,750,000  
Offering costs (53,390,327) (53,390,327)      
Sale of private placement warrants to Sponsor in private placement 6,858,410 6,858,410      
Shares subject to possible redemption (903,981,360) (903,972,320)   $ (9,040)  
Shares subject to possible redemption (in shares)       (90,398,136)  
Net loss (2,223,991)   (2,223,991)    
Ending balance at Mar. 31, 2021 $ 5,000,002 $ 7,239,434 $ (2,242,611) $ 735 $ 2,444
Ending balance (in shares) at Mar. 31, 2021       7,351,864 24,437,500